Geron
GERN
#6613
Rank
NZ$1.31 B
Marketcap
NZ$2.05
Share price
1.27%
Change (1 day)
-20.21%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2025 (TTM): -NZ$87.54 Million

According to Geron's latest financial reports the company's current earnings are NZ$0.18 Billion. , an increase over its 2024 earnings that were of -NZ$0.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2025

Annual earnings

Year Earnings Change
2025 -NZ$87.42 Million-67.42%
2024 -NZ$0.27 Billion-11.23%
2023 -NZ$0.31 Billion30.22%
2022 -NZ$0.24 Billion20.15%
2021 -NZ$0.2 Billion50.08%
2020 -NZ$0.13 Billion4.46%
2019 -NZ$0.13 Billion130.68%
2018 -NZ$53.43 Million8.84%
2017 -NZ$49.09 Million-3.08%
2016 -NZ$50.65 Million-22080.6%
2015 NZ$0.23 M-100.38%
2014 -NZ$61.19 Million-7.14%
2013 -NZ$65.89 Million
2011 -NZ$0.16 Billion19.04%
2010 -NZ$0.14 Billion8.45%
2009 -NZ$0.13 Billion-2.51%
2008 -NZ$0.13 Billion14.65%
2007 -NZ$0.11 Billion32.68%
2006 -NZ$81.43 Million25.59%
2005 -NZ$64.84 Million4.36%
2004 -NZ$62.13 Million19.73%
2003 -NZ$51.89 Million-15.46%
2002 -NZ$61.38 Million1.94%
2001 -NZ$60.21 Million33.59%
2000 -NZ$45.07 Million27.53%
1999 -NZ$35.34 Million63.13%
1998 -NZ$21.67 Million15.6%
1997 -NZ$18.75 Million-10.66%
1996 -NZ$20.98 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
NZ$16.84 B-19,369.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
NZ$3.04 B-3,588.90%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-NZ$0.12 Billion 36.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
NZ$0.21 B-342.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-NZ$16.32 Million-81.34%๐Ÿ‡บ๐Ÿ‡ธ USA